Novogen Limited (KZIA)
(Delayed Data from NSDQ)
$0.37 USD
-0.02 (-4.88%)
Updated Apr 25, 2024 03:57 PM ET
After-Market: $0.36 -0.01 (-2.70%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Novogen Limited falls in the month of June.
All items in Millions except Per Share data.
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 4 | 5 | 21 | 6 | 4 |
Receivables | 3 | 0 | 0 | 1 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 1 | 0 | 1 | 0 | 0 |
Total Current Assets | 7 | 6 | 22 | 7 | 5 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 5 | 5 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 12 | 15 | 16 | 8 | 10 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 19 | 25 | 43 | 15 | 15 |
Liabilities & Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 3 | 4 | 2 | 1 |
Current Portion Long-Term Debt | 1 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 1 | 3 | 1 | 0 |
Total Current Liabilities | 5 | 3 | 6 | 3 | 1 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 2 | 2 | 2 | 3 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 7 | 7 | 0 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 11 | 12 | 15 | 6 | 5 |
Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 66 | 61 | 60 | 33 | 26 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -60 | -50 | -33 | -24 | -18 |
Other Equity | 2 | 2 | 1 | 1 | 2 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 8 | 14 | 28 | 9 | 10 |
Total Liabilities & Shareholder's Equity | 19 | 25 | 43 | 15 | 15 |
Total Common Equity | 8 | 14 | 28 | 9 | 10 |
Shares Outstanding | 16.30 | 13.80 | 13.20 | 9.40 | 6.20 |
Book Value Per Share | 0.50 | 0.98 | 2.14 | 1.01 | 1.64 |
Fiscal Year End for Novogen Limited falls in the month of June.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,997 | -99,999 | 4 | -99,999 |
Receivables | NA | 2 | NA | 3 | NA |
Notes Receivable | NA | NA | NA | 0 | NA |
Inventories | NA | NA | NA | 0 | NA |
Other Current Assets | NA | 0 | NA | 1 | NA |
Total Current Assets | NA | 5 | NA | 7 | NA |
Net Property & Equipment | NA | NA | NA | 0 | NA |
Investments & Advances | NA | NA | NA | 0 | NA |
Other Non-Current Assets | NA | 0 | NA | 0 | NA |
Deferred Charges | NA | NA | NA | 0 | NA |
Intangibles | NA | 11 | NA | 12 | NA |
Deposits & Other Assets | NA | NA | NA | 0 | NA |
Total Assets | NA | 16 | NA | 19 | NA |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | NA | 0 | NA |
Accounts Payable | NA | 4 | NA | 3 | NA |
Current Portion Long-Term Debt | NA | 0 | NA | 1 | NA |
Current Portion Capital Leases | NA | NA | NA | 0 | NA |
Accrued Expenses | NA | NA | NA | 0 | NA |
Income Taxes Payable | NA | NA | NA | 0 | NA |
Other Current Liabilities | NA | 3 | NA | 1 | NA |
Total Current Liabilities | NA | 7 | NA | 5 | NA |
Mortgages | NA | NA | NA | 0 | NA |
Deferred Taxes/Income | NA | 1 | NA | 2 | NA |
Convertible Debt | NA | NA | NA | 0 | NA |
Long-Term Debt | NA | NA | NA | 0 | NA |
Non-Current Capital Leases | NA | NA | NA | 0 | NA |
Other Non-Current Liabilities | NA | NA | 4 | NA | |
Minority Interest (Liabilities) | NA | NA | NA | 0 | NA |
Total Liabilities | NA | 12 | NA | 11 | NA |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | NA | 0 | NA |
Common Stock (Par) | NA | 64 | NA | 66 | NA |
Capital Surplus | NA | NA | NA | 0 | NA |
Retained Earnings | NA | -64 | NA | -60 | NA |
Other Equity | NA | 3 | NA | 2 | NA |
Treasury Stock | NA | NA | NA | 0 | NA |
Total Shareholder's Equity | NA | 3 | NA | 8 | NA |
Total Liabilities & Shareholder's Equity | NA | 16 | NA | 19 | NA |
Total Common Equity | 0 | 100,002 | 0 | 8 | 0 |
Shares Outstanding | 16.30 | 16.30 | 16.30 | 16.30 | 13.80 |
Book Value Per Share | 0.00 | 6,135.12 | 0.00 | 0.50 | 0.00 |